Gastric cancer is the third leading cause of cancer-related death worldwide. Surgery is currently the only curative treatment strategy. Chemotherapy has shown limited efficacy in advanced gastric cancer patients with ...Gastric cancer is the third leading cause of cancer-related death worldwide. Surgery is currently the only curative treatment strategy. Chemotherapy has shown limited efficacy in advanced gastric cancer patients with a median overall survival of less than one year. Thus, new treatments are urgently needed. Trastuzumab and Ramucirumab are the only targeted therapies approved currently. Most Phase Ⅲ clinical trials evaluating targeted drugs in gastric cancer have failed. This review will evaluate relevant clinical trials with targeted therapies performed in gastric cancer patients, discuss the possible reasons for the failure, and indicate new possibilities to enhance gastric cancer treatment.展开更多
Objectives:In recent years,the use of mobile health applications(mHealth apps)to deliver care for patients with breast cancer has increased exponentially.This study aimed to summarize the available evidence on develop...Objectives:In recent years,the use of mobile health applications(mHealth apps)to deliver care for patients with breast cancer has increased exponentially.This study aimed to summarize the available evidence on developing mHealth apps to care for patients with breast cancer and identify the need for systematic efforts.Methods:A scoping review was performed according to Arksey and O’Malley’s framework,aiming to identify eligible research studies in PubMed,CINAHL,and Web of Science between January 2010 and December 2020.All identified studies were screened,extracted,and analyzed independently by two reviewers.Results:A total of 676 studies were retrieved,and eight eligible studies were finally included.Four themes emerged:the involvement of patients and health professionals in the phases of design and development,patients’preferences,the characteristics of patients,and the motivators to use mHealth apps.The results indicated promising prospects for using mHealth apps to care for patients with breast cancer and identified the need for systematic efforts to develop and validate relevant apps.Conclusions:The attributes of patient characteristics,needs,and patient-reported outcomes data are vital components for developing mHealth apps for patients with breast cancer.Additionally,collaborative efforts,including patients,nurses,and other significant health professionals,should develop mHealth apps for breast cancer care.Additional research focusing on the design and development of mHealth apps for patients with breast cancer is warranted.展开更多
Long noncoding RNAs(lncRNAs)play important roles in human diseases including vascular disease.Given the large number of lncRNAs,however,whether the majority of them are associated with vascular disease remains unknown...Long noncoding RNAs(lncRNAs)play important roles in human diseases including vascular disease.Given the large number of lncRNAs,however,whether the majority of them are associated with vascular disease remains unknown.For this purpose,here we present a genomic location based bioinformatics method to predict the lncRNAs associated with vascular disease.We applied the presented method to globally screen the human lncRNAs potentially involved in vascular disease.As a result,we predicted 3043 putative vascular disease associated lncRNAs.To test the accuracy of the method,we selected 10 lncRNAs predicted to be implicated in proliferation and migration of vascular smooth muscle cells(VSMCs)for further experimental validation.The results confirmed that eight of the 10 lncRNAs(80%)are validated.This result suggests that the presented method has a reliable prediction performance.Finally,the presented bioinformatics method and the predicted vascular disease associated lncRNAs together may provide helps for not only better understanding of the roles of lncRNAs in vascular disease but also the identification of novel molecules for the diagnosis and therapy of vascular disease.展开更多
基金Supported by a grant from the National Natural Science Foundation of China(No.81372664)
文摘Gastric cancer is the third leading cause of cancer-related death worldwide. Surgery is currently the only curative treatment strategy. Chemotherapy has shown limited efficacy in advanced gastric cancer patients with a median overall survival of less than one year. Thus, new treatments are urgently needed. Trastuzumab and Ramucirumab are the only targeted therapies approved currently. Most Phase Ⅲ clinical trials evaluating targeted drugs in gastric cancer have failed. This review will evaluate relevant clinical trials with targeted therapies performed in gastric cancer patients, discuss the possible reasons for the failure, and indicate new possibilities to enhance gastric cancer treatment.
基金This study was supported by the Natural Science Foundation of China(71874032)the Natural Science Foundation of China(72074054).
文摘Objectives:In recent years,the use of mobile health applications(mHealth apps)to deliver care for patients with breast cancer has increased exponentially.This study aimed to summarize the available evidence on developing mHealth apps to care for patients with breast cancer and identify the need for systematic efforts.Methods:A scoping review was performed according to Arksey and O’Malley’s framework,aiming to identify eligible research studies in PubMed,CINAHL,and Web of Science between January 2010 and December 2020.All identified studies were screened,extracted,and analyzed independently by two reviewers.Results:A total of 676 studies were retrieved,and eight eligible studies were finally included.Four themes emerged:the involvement of patients and health professionals in the phases of design and development,patients’preferences,the characteristics of patients,and the motivators to use mHealth apps.The results indicated promising prospects for using mHealth apps to care for patients with breast cancer and identified the need for systematic efforts to develop and validate relevant apps.Conclusions:The attributes of patient characteristics,needs,and patient-reported outcomes data are vital components for developing mHealth apps for patients with breast cancer.Additionally,collaborative efforts,including patients,nurses,and other significant health professionals,should develop mHealth apps for breast cancer care.Additional research focusing on the design and development of mHealth apps for patients with breast cancer is warranted.
基金supported by the National Natural Science Foundation of China(91339106)National High Technology Research and Development Program of China(2014AA021102)
文摘Long noncoding RNAs(lncRNAs)play important roles in human diseases including vascular disease.Given the large number of lncRNAs,however,whether the majority of them are associated with vascular disease remains unknown.For this purpose,here we present a genomic location based bioinformatics method to predict the lncRNAs associated with vascular disease.We applied the presented method to globally screen the human lncRNAs potentially involved in vascular disease.As a result,we predicted 3043 putative vascular disease associated lncRNAs.To test the accuracy of the method,we selected 10 lncRNAs predicted to be implicated in proliferation and migration of vascular smooth muscle cells(VSMCs)for further experimental validation.The results confirmed that eight of the 10 lncRNAs(80%)are validated.This result suggests that the presented method has a reliable prediction performance.Finally,the presented bioinformatics method and the predicted vascular disease associated lncRNAs together may provide helps for not only better understanding of the roles of lncRNAs in vascular disease but also the identification of novel molecules for the diagnosis and therapy of vascular disease.
